Pan, Y. et al. developed cancer stem cell–specific targeted mSiO2-dendritic polyglycerol (mSiO2-dPG) nanocarriers for simultaneously delivering the chemotherapy drug DOX along with the P-gp inhibitor tariquidar (Tar) for enhanced chemotherapy to overcome MDR in breast cancer stem cells. Here, PGP is linked to breast cancer.